In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression

Oncology (Switzerland)

Volumn 84, Issue 6, 2013, Pages 356-361

  Shimazaki, Jiro ^a   Goto, Yoshihisa ^a   Nishida, Kiyotaka ^a   Tabuchi, Takanobu ^a   Motohashi, Gyo ^a   Ubukata, Hideyuki ^a   Tabuchi, Takafumi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Granulocyte lymphocyte ratio; Inflammatory cytokines; Interleukin 6; Pre operative stage; Prognostic markers

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; GRANULOCYTE LYMPHOCYTE RATIO; HUMAN; LEUKOCYTE COUNT; MALE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; BLOOD CELL RATIO; COLORECTAL SURGERY; CONTROLLED STUDY; CORRELATIONAL STUDY; LEUKOCYTE DIFFERENTIAL COUNT; LYMPH NODE METASTASIS; PREOPERATIVE EVALUATION; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GRANULOCYTES; HUMANS; INTERLEUKIN-6; LYMPHOCYTE COUNT; LYMPHOCYTES; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877861593     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000350836     Document Type: Article

References (37)

1. Knupfer H, Preiss R: Serum interleukine-6 levels in colorectal cancer patients - a summary of published results. Int J Colorectal Dis 2010; 25: 135-140.
2. Grivennikov SI, Karin M: Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 2011; 70: 104-108.
3. Dantzer R: Cytokine-induced sickness behavior: Mechanism and implications. Ann NY Acad Sci 2001; 933: 222-234.
4. Miller AH: Cytokines and sickness behavior: Implications for cancer care and control. Brain Behav Immun 2003; 17: 132-134.
5. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002; 420: 860-867.
6. Petrie HT, Llassen LW, Kay HD: Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 1985; 134: 230-234.
7. Suzuki S, Toyabe S, Moroda T, et al: Circadian rhythm of leucocytes and lymphocyte subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol 1997; 110: 500-508.
8. Abo T, Kawamura T, Kawamura H, et al: Relationship between diseases accompanied by tissue destruction and granulocytes with surface adrenergic receptors. Immunologic Res 2007; 37: 201-210.
9. Tabuchi T, Shimazaki J, Satani T, et al: The perioperative granulocyte/lymphocyte ratio is a clinically relevant marker of surgical stress in patients with colorectal cancer. Cytokine 2011; 53: 243-248.
10. Dinarello CA: Proinflammatory and anti-inflammatory cytokines as mediators in pathogenesis of septic shock. Chest 1997; 112: 321s-329s.
11. Malicki S, Winiarski K, Matlok M, et al: IL-6 and IL-8 responses of colorectal cancer in vivo and in vitro cancer cells subjected to simvastatin. J Physio Pharmacol 2009; 60: 141-145.
12. Ardestani SK, Inserra P, Solkoff D, et al: The role of cytokines and chemokines on tumor progression: A review. Cancer Detect Prev 1999; 23: 215-225.
13. Esfandi F, Mohammadzadeh Ghobadloo S, Basati G: Interleukin-6 level in patients with colorectal cancer. Cancer Lett 2006; 244: 76-78.
14. Castell JV, Gomes-Lechon MJ, David M, et al: Acute-phase response of human hepatocyte: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-1186.
15. Nikiteas NI, Tzanakis N, Gazouli M, et al: Serum IL-6: TNFα and CRP levels in Greek colorectal cancer patients: Prognostic implications. World J Gastroenterol 2005; 11: 1639-1643.
16. Zahlten-Hinguranage A, Goldschmidt H, Gremer FW, et al: Preoperative elevation of serum C-reactive protein is predictive for prognosis in myeloma bone disease after surgery. Brit J Cancer 2006; 95: 782-787.
17. McMillan DC, Canna K, MacArdle CS: Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Brit J Surg 2003; 90: 215-219.
18. Wong VKH, Malik HZ, Hamady ZZR, et al: C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Brit J Cancer 2007; 96: 222-225.
19. Galizia G, Orditura M, Romano C, et al: Prognostic significance of circulation IL-10 and IL-6 serum level in colon cancer patients undergoing surgery. Clin Immunol 2002; 102: 169-178.
20. Ikeguchi M, Hatada T, Yamamoto M, et al: Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer 2009; 12: 95-100.
21. Belluco C, Nitti D, Frantz M, et al: Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol 2000; 7: 133-138.
22. Nakagoe T, Tsuji T, Sawai T, et al: The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer. Anticancer Res 2003; 23: 3561-3564.
23. Gregory AD, Houghton AM: Tumor-associated neutrophils: New targets for cancer therapy. Cancer Res 2011; 71: 2411-2416.
24. Aaltomaa S, Lipponen P, Eskelinen M, et al: Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer 1992; 28: 859-864.
25. Jensen HK, Donckov F, Marcussen N, et al: Presence of intratumoral neutrophils is an independent prognostic fctor in localized renal carcinoma. J Clin Oncol 2009; 27: 4709-4717.
26. Wislez M, Rabbe N, Maechal J, et al: Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: Role in tumor progression and death. Cancer Res 2003; 63: 1405-1412.
27. Tabuchi T, Soma T, Komai T, et al: Reduction of VX2 transplanted tumor by granulocyte depletion using extracorporeal circulation on rabbit models. Anticancer Res 1992; 12: 795-798.
28. Liu H, Ubukata H, Tabuchi T, et al: It is possible that tumour-infiltrating granulocytes promote tumour progression. Oncology Rep 2009; 22: 29-33.
29. Kusumanto YH, Dam WA, Hospers GA, et al: Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003; 6: 283-287.
30. Kay HD, Smith DL: Regulation of human lymphocyte mediated natural killer (NK) cell activity: Inhibition in vitro by peripheral blood granulocytes. J Immunol 1983; 30: 475-483.
31. Petrie HT, Klassen LW, Kay HD: Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 1985; 134: 230-234.
32. Tanner J, Tosato G: Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest 1991; 88: 239-247.
33. Fumagalli LA, Vinke J, Hoff W, et al: Lymphocyte counts independently predict overall survival in advanced cancer patients: A biomarker for IL-2 immunotherapy. J Immunother 2003; 26: 394-402.
34. Fogar P, Sperti C, Basso D, et al: Decreased total lymphocyte counts in pancreatic cancer: An index of adverse outcome. Pancreas 2006; 32: 22-28.
35. Halazun KJ, Aldoori A, Malik HZ, et al: Elevated preoperative neutrophils to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008; 34: 55-60.
36. Yamanaka T, Matsumoto S, Teramukai S, et al: The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007; 73: 215-220.
37. Walsh SR, Cook EJ, Goulder F, et al: Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-184.